TIZABI, Yousef, Bruk GETACHEW, Clifford L. FERGUSON, Antonei B. CSOKA, Karl M. THOMPSON, Alejandra GOMEZ-PAZ, Jana RUDÁ and Robert E. TAYLOR. Low Vs. High Alcohol: Central Benefits Vs. Detriments. Neurotoxicity research. New York: Springer, 2018, vol. 34, No 4, p. 860-869. ISSN 1029-8428. Available from: https://dx.doi.org/10.1007/s12640-017-9859-x.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Low Vs. High Alcohol: Central Benefits Vs. Detriments
Name in Czech Vysoký versus nízký příjem alkoholu: pozitivní a negativní centrální účinky
Authors TIZABI, Yousef (840 United States of America, guarantor), Bruk GETACHEW (840 United States of America), Clifford L. FERGUSON (840 United States of America), Antonei B. CSOKA (840 United States of America), Karl M. THOMPSON (840 United States of America), Alejandra GOMEZ-PAZ (484 Mexico), Jana RUDÁ (203 Czech Republic, belonging to the institution) and Robert E. TAYLOR (840 United States of America).
Edition Neurotoxicity research, New York, Springer, 2018, 1029-8428.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30103 Neurosciences
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 3.311
RIV identification code RIV/00216224:14110/18:00102160
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1007/s12640-017-9859-x
UT WoS 000447760400009
Keywords in English Neurotoxicity; Neuroprotection; Major depressive disorder; Neurotrophic factors; Inflammatory mediators; Sex differences
Tags 14110516, rivok
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 10/2/2019 15:40.
Abstract
In this review, the mechanism(s) leading to the detrimental effects of high BAC, as well as the beneficial effects of low BAC will be discussed. In addition, gender consideration is touched upon.
Links
MUNI/A/1063/2016, interní kód MUName: Experimentální a translační farmakologický výzkum a vývoj
Investor: Masaryk University, Category A
PrintDisplayed: 26/5/2024 11:24